About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 440 record(s)
Req # A-2020-00024
An electronic copy of the agreement (MOU) between Simon Fraser University and NSERC (or Tri-agency), under 4.1 Agreement on the Administration of Agency Grants and Awards by Research Institutions, Tri-Agency Framework: Responsible Conduct of Research. If there are any other MOUs between Simon Fraser University and NSERC, under Tri-Agency Framework: Responsible Conduct of Research, an electronic copy is requested as well. Date range: anytime between January 2014 and October 2020. If there exists multiple agreements/MOU, where the subject matter in the MOUs is identical or close enough to be identical, one agreement/ MOU would suffice.Organization: Natural Sciences and Engineering Research Council of Canada
October 2020
Req # A-2017-00008
All NSERC records relevant the external investigation { (SRCR File #XXXX) including, but not limited to, memos, notes, conference call transcript, letters, and e-mails exchanged between a) the Secretariat and the Investigators, b) the Secretariat and the Instituion, and c) the Secretariat and the Presidents of the three federal agencies (CIHR, NSERC, and SSHRC); time frame 2015 to 2017.Organization: Natural Sciences and Engineering Research Council of Canada
October 2020
Nothing to report this month
Organization: Canada Foundation for Innovation
Nothing to report this month
Organization: Canadian Grain Commission
Nothing to report this month
Organization: Canadian Museum of Nature
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A3-2020-00005
Please provide in spreadsheet form the total amount of expenses incurred between March 1st 2020 and the date on which this request is received detailing all expenses with the 2020/2021 object codes 1231, 1246, and 0533. Provide a breakdown of expenses incurred and for each expense, provide the name of the service provider/contractor, a description of the product or service rendered, the date, and the total amount of the expense. When this data does not exist in the aforementioned format, provide the entirety of records (including receipts, purchase orders, and service contracts) pertaining to the expense. Search through electronic records only, unless data is not available in that format. Exclude cabinet confidences. Remove French versions of records if English ones exist. Provide the final version of documents or last draft if the final version is not availableOrganization: Canadian Grain Commission
September 2020
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020